MENU

November 2021

Junshi Biosciences Announces Approval of Supplemental New Drug Application by NMPA for Toripalimab in Combination with Cisplatin and Gemcitabine as First-Line Treatment for Patients with Locally Recurrent or Metastatic Nasopharyngeal Carcinoma

4th approved indication for toripalimab SHANGHAI, China, Nov. 30, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) announced today that the National Medical Products Administration (NMPA) of China has approved its supplemental New

Read More ➜

Egyptian Int’l Defence Expo Kicks Off In Cairo

CAIRO – Egypt held yesterday, the second edition of its largest international defence expo, EDEX 2021, with more than 400 defence companies from 42 countries, showcasing their up-to-date defence products.Inaugurated by Egyptian President, Abdel-Fattah …

Read More ➜

Recent News

ADVERTISMENT